Thrive Tribe Technologies Signs Exclusive Distribution Agreement with NATO-Registered Defence Agency EAV
Key Takeaways
- •Thrive Tribe Technologies signed a three-year exclusive distribution agreement with EAV, a NATO-registered Canadian defence procurement agency, to market its WooBoard and REFFIND HR platforms to NATO armed forces.
- •EAV must generate at least US$5 million in turnover by the end of Year 1 and at least US$15 million by the end of Year 2 to retain exclusivity, and is entitled to 20% of revenue under the deal.
- •The agreement follows 1TT's May announcement relaunching REFFIND and WooBoard into the military and defence space, targeting troop recognition, secure communications, and personnel wellbeing.
- •NATO members agreed at the 2025 Summit to raise defence investment to five per cent of GDP annually by 2035, with European Allies and Canada increasing combined defence spending by close to 20% in 2025.
- •Prior to market open, 1TT shares were steady at 0.2 cents, giving the company a market capitalisation of $7.482 million.

Thrive Tribe Technologies (ASX: 1TT) has entered into a multi-million dollar, three-year exclusive distribution agreement with Effective Acceleration Ventures (EAV), a NATO-registered defence procurement agency.
EAV is a Canadian defence supplier and services contractor whose activities span defence procurement, equipment and parts supply, information technology and telecommunications consulting, controlled technology, and government contracting.
Under the agreement, EAV becomes 1TT's exclusive distribution partner, tasked with marketing and distributing the company's modernised WooBoard and REFFIND HR platforms to armed forces, military organisations, troops, and personnel of NATO member states. For 1TT, a small-cap company with a market capitalisation under $10 million, the deal represents a shift toward recurring, contract-backed revenue in a sector with structured, long-cycle procurement processes — a channel typically difficult for micro-cap software vendors to access without an established in-country partner.
To retain exclusivity, EAV must generate at least US$5 million in turnover by the end of Year 1 and at least US$15 million by the end of Year 2. EAV is entitled to 20% of revenue generated under the agreement. These turnover thresholds serve as measurable milestones investors can track through the agreement's term to gauge whether the partnership is converting into actual sales.
The signing follows 1TT's announcement in May of the relaunch of REFFIND and WooBoard into the military and defence space. The platforms are regarded as essential tools for improving troop recognition, providing secure communications, increasing workforce productivity, supporting mental health and wellbeing, and enabling HR support for deployed personnel.
Non-executive director Wes Culley said the EAV distribution agreement positions 1TT to capture market share in a defence sector that is rapidly increasing both its overall spending and its investment in personnel-focused technology.
The military telemedicine market is one of the fastest-growing segments of defence health technology, with mental health and PTSD management applications forecast to expand faster than any other use case through to 2035. More broadly, the global mental health technology market is projected to grow from roughly US$12 billion in 2026 to more than US$56 billion by 2035, with the employer-provided segment expected to be the fastest-growing customer category as organisations formalise workplace wellbeing programs.
NATO member states agreed at the 2025 NATO Summit to lift defence investment to five per cent of GDP annually by 2035, with European Allies and Canada already increasing combined defence expenditure by close to 20% in 2025. That pledged spending uplift frames the addressable budget pool into which the EAV partnership is intended to sell.
Prior to markets opening, 1TT shares were steady at 0.2¢, with a market capitalisation of $7.482 million.
The material provided in this article is for information only and should not be treated as investment advice. Readers are encouraged to conduct their own research and consult a certified financial advisor before making any investment decisions.